Your browser doesn't support javascript.
loading
Efficacy and Safety of Ribociclib With Letrozole in US Patients Enrolled in the MONALEESA-2 Study.
Yardley, Denise A; Hart, Lowell; Favret, Anne; Blau, Sibel; Diab, Sami; Richards, Donald; Sparano, Joseph; Beck, J Thad; Richards, Paul; Ward, Patrick; Ramaswamy, Bhuvaneswari; Tsai, Michaela; Blackwell, Kimberly; Pluard, Timothy; Tolaney, Sara M; Esteva, Francisco J; Truica, Cristina I; Alemany, Carlos; Volas-Redd, Gena; Shtivelband, Mikhail; Purkayastha, Das; Dalal, Anand A; Miller, Michelle; Hortobagyi, Gabriel N.
Afiliação
  • Yardley DA; Sarah Cannon Research Institute, Nashville, TN; Tennessee Oncology, Nashville, TN. Electronic address: dyardley@tnonc.com.
  • Hart L; Sarah Cannon Research Institute, Nashville, TN; Florida Cancer Specialists, Fort Myers, FL.
  • Favret A; US Oncology Network, McKesson Specialty Health, The Woodlands, TX; Virginia Cancer Specialists, PC, Fairfax, VA.
  • Blau S; Division of Hematology-Oncology, Northwest Medical Specialties, PLLC, Puyallup, WA.
  • Diab S; US Oncology Network, McKesson Specialty Health, The Woodlands, TX; Rocky Mountain Cancer Centers, LLP, Aurora, CO.
  • Richards D; US Oncology Network, McKesson Specialty Health, The Woodlands, TX; Texas Oncology, PA, Tyler, TX.
  • Sparano J; Department of Oncology, Montefiore Medical Center, Bronx, NY.
  • Beck JT; Highlands Oncology Group, Fayetteville, AR.
  • Richards P; US Oncology Network, McKesson Specialty Health, The Woodlands, TX; Oncology and Hematology Associates of Southwest Virginia, Inc, DBA Blue Ridge Cancer Care, Salem, VA.
  • Ward P; US Oncology Network, McKesson Specialty Health, The Woodlands, TX; Oncology Hematology Care, Cincinnati, OH.
  • Ramaswamy B; Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center/Wexner Medical Center, Columbus, OH.
  • Tsai M; Virginia Piper Cancer Institute, Allina Health, Minneapolis, MN.
  • Blackwell K; Department of Medicine, Duke University Medical Center, Durham, NC.
  • Pluard T; Saint Luke's Cancer Institute, Saint Luke's Health Systems, Kansas City, MO.
  • Tolaney SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Esteva FJ; Department of Medicine, Perlmutter Cancer Center at NYU Langone Health, New York, NY.
  • Truica CI; Department of Medicine, Pennsylvania State Cancer Institute, Hershey, PA.
  • Alemany C; Florida Hospital Cancer Institute, Orlando, FL.
  • Volas-Redd G; Georgia Cancer Specialists affiliated with Northside Hospital Cancer Institute, Atlanta, GA.
  • Shtivelband M; Ironwood Cancer and Research Center, Chandler, AZ.
  • Purkayastha D; Novartis Pharmaceuticals Corporation, East Hanover, NJ.
  • Dalal AA; Novartis Pharmaceuticals Corporation, East Hanover, NJ.
  • Miller M; Novartis Pharmaceuticals Corporation, East Hanover, NJ.
  • Hortobagyi GN; Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
Clin Breast Cancer ; 19(4): 268-277.e1, 2019 08.
Article em En | MEDLINE | ID: mdl-31160171
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article